S. 527: Prescription Pricing for the People Act of 2025

S. 527 is a federal bill in the 119th Congress. Currently, federal oversight of how prescription drug middlemen operate and influence costs is limited to general antitrust enforcement without specific mandated reporting on supply chain fairness. Under this legislation, the Federal Trade Commission must… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.